Journal article
Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys
Louisa Degenhardt, Meyer Glantz, Sara Evans-Lacko, Ekaterina Sadikova, Nancy Sampson, Graham Thornicroft, Sergio Aguilar-Gaxiola, Ali Al-Hamzawi, Jordi Alonso, Laura Helena Andrade, Ronny Bruffaerts, Brendan Bunting, Evelyn J Bromet, Jose Miguel Caldas de Almeida, Giovanni de Girolamo, Silvia Florescu, Oye Gureje, Josep Maria Haro, Yueqin Huang, Aimee Karam Show all
World Psychiatry | WILEY | Published : 2017
DOI: 10.1002/wps.20457
Grants
Awarded by US National Institute of Mental Health
Awarded by US Public Health Service
Awarded by Fogarty International Center
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by NHMRC Principal Research Fellowship
Funding Acknowledgements
The authors are grateful to M. Kumvaj for her assistance with the systematic literature search. They also thank the staff of the WMHS Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork and consultation on data analysis. The WHO's WMHS are supported by the US National Institute of Mental Health (R01 MH070884), the MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The views expressed in this report are those of the authors and should not be construed to represent the views or policies of the WHO, other sponsoring organizations, agencies, or governments. This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (no. 1081984). L. Degenhardt is supported by an NHMRC Principal Research Fellowship (no. 1041472).